City National Bank’s Array Biopharma Inc ARRY Stock Holding History

City National Bank’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$151K	Sell	33,035 -301,715	-90%	-$1.79M	﹤0.01%	791
2015 Q2	$2.41M	Sell	334,750 -652,212	-66%	-$4.81M	0.02%	359
2015 Q1	$7.27M	Buy	986,962 +243,485	+33%	+$1.73M	0.06%	246
2014 Q4	$3.52M	Buy	743,477 +56,464	+8%	+$223K	0.03%	308
2014 Q3	$2.45M	Buy	687,013 +34,498	+5%	+$136K	0.02%	351
2014 Q2	$2.98M	Buy	652,515 +336,685	+107%	+$1.39M	0.03%	333
2014 Q1	$1.49M	Buy	315,830 +110,285	+54%	+$555K	0.02%	347
2013 Q4	$1.03M	Buy	205,545 +87,225	+74%	+$475K	0.02%	417
2013 Q3	$736K	Sell	118,320 -3,150	-3%	-$18.7K	0.01%	449
2013 Q2	$551K	Buy	+121,470	New	+$653K	0.01%	511

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

City National Bank's ARRY Position: Q3 2015 in Review

City National Bank reduced its Array Biopharma Inc (ARRY) stake by 90% in Q3 2015, selling an estimated $1.79M and leaving 33,035 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #791.

City National Bank first reported a position in ARRY in Q2 2013 and has held it in 10 quarters since. The position peaked at $7.27M in Q1 2015. 157 funds tracked by Wall St. Rank hold ARRY as of Q3 2015.

City National Bank held 33,035 shares of Array Biopharma Inc worth $151K as of Q3 2015.
City National Bank sold 301,715 Array Biopharma Inc shares in Q3 2015, an estimated $1.79M.
Array Biopharma Inc made up ﹤0.01% of City National Bank's portfolio in Q3 2015, its #791 holding.
City National Bank first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 10 quarters since.
City National Bank's Array Biopharma Inc position peaked at $7.27M in Q1 2015.
157 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.